PURPOSE: To summarize the characteristics of @entity16970 ( @entity16970 ) and to evaluate the therapeutic effect of drug therapy combined with transarterial embolization. @entity1 AND METHODS: From 2007 to 2011, 6 cases of @entity16970 that underwent drug therapy and transarterial embolization were retrospectively analyzed, comprising of 3 male and 3 female @entity1 ; the ages of the @entity1 ranged from 3 to 40 days. The lesions were located in the temporal region (1 of 6, 16.7%), parotid region (2 of 6, 33.3%), or submandibular region and neck (3 of 6, 50%). All the @entity1 were followed for 12 to 18 months. Therapeutic outcomes were assessed by evaluating the platelet count, coagulation parameters, and size of the lesion. RESULTS: Positive responses were visible shrinkage of the @entity2695 or lightening of the skin color of the @entity5 (or both) within 8 to 72 hours in 4 @entity1 (66.67%). These occurred within 1 week in 5 @entity1 (83.33%) and within 2 weeks in all @entity1 (100%). The mean platelet count before treatment was 18,000/L (range, 8,000 to 33,000/L). After the first week of medical treatment, the mean platelet count increased to above 80,000/L in 5 @entity1 (83.33%); it began to increase on the second day after embolization and reached 102,000/L in 1 @entity1 (16.67%). All 6 cases (100%) showed good results with treatment. A 12- to 18-month follow-up evaluation was obtained for all treated @entity1 , and no rebound growth or platelet count decreases were observed. No severe or obvious adverse complications were noted during all treatment courses. CONCLUSIONS: For most @entity2695 presenting with @entity16970 , good results can be obtained with systemic medical treatment. Transcatheter @entity1416 with @entity4832 particles combined with systemic medical treatment should be considered an efficacious and important therapeutic option for challenging cases.

Comprehensive therapy for @entity2695 presenting with XXXX in the maxillofacial region.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity4832 :: ('MESH:D011142', 'Chemical') :: ['polyvinyl alcohol'] @entity2695 :: ('MESH:D006391', 'Disease') :: ['hemangioma', 'hemangiomas'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cutaneous tumor'] @entity16970 :: ('MESH:D059885', 'Disease') :: ['KMS', 'Kasabach-Merritt syndrome'] @entity1416 :: ('MESH:D020762', 'Disease') :: ['arterial embolization']
@entity16970 :: (MESH:D059885,Disease) :: ['kasabach-merritt syndrome']
